» Authors » Anna Boixadera

Anna Boixadera

Explore the profile of Anna Boixadera including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 316
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Garrido-Marin M, Kirkegaard Biosca E, Boixadera A, Fischer Fernandez R, Sanchez Vela L, Pardo Aranda A, et al.
Ocul Immunol Inflamm . 2023 Jan; 32(6):858-862. PMID: 36696576
Background: endophthalmitis is a severe complication of candidemia. Currently, the recommended treatment of fungal endophthalmitis is a combination of intravitreal and systemic antifungal drugs, and in some cases vitrectomy is...
2.
Rivera-Esteban J, Pons M, Planas A, Manzano-Nunez R, Hernandez C, Simo-Servat O, et al.
Gastroenterol Hepatol . 2022 Nov; 46(9):682-691. PMID: 36435379
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is associated with poorer glycemic control and a higher risk of type-2 diabetes (T2D) complications, extrahepatic and cardiovascular disease (CVD). Our study...
3.
Zarranz-Ventura J, Romero-Nunez B, Bernal-Morales C, Velazquez-Villoria D, Sala-Puigdollers A, Figueras-Roca M, et al.
BMC Ophthalmol . 2020 Nov; 20(1):443. PMID: 33176749
Background: To identify different response patterns to intravitreal dexamethasone implants (IDI) in naïve and previously treated (PT) diabetic macular edema (DME) eyes in a real-life setting. Methods: 342 IDI injections...
4.
Simo R, Baneras J, Hernandez C, Rodriguez-Palomares J, Valente F, Gutierrez L, et al.
BMJ Open Diabetes Res Care . 2020 Jan; 7(1):e000845. PMID: 31908800
Objective: Detection of subclinical cardiovascular disease (CVD) has significant impact on the management of type 2 diabetes. We examined whether the assessment of diabetic retinopathy (DR) is useful for identifying...
5.
Zarranz-Ventura J, Sala-Puigdollers A, Velazquez-Villoria D, Figueras-Roca M, Copete S, Distefano L, et al.
PLoS One . 2019 Jan; 14(1):e0209997. PMID: 30608950
Purpose: To evaluate the long-term cumulative probability of intraocular pressure (IOP) elevation with the intravitreal dexamethasone implant (IDI) when used to treat different indications: diabetic macular edema, uveitis, retinal vein...
6.
Martinez-Castillo V, Boixadera A
Ophthalmology . 2017 May; 124(6):e52. PMID: 28528838
No abstract available.
7.
Distefano L, Garcia-Arumi J, Martinez-Castillo V, Boixadera A
J Ophthalmol . 2017 Mar; 2017:2407037. PMID: 28348882
Diabetic macular edema (DME) is the most common cause of vision loss in diabetic patients. Thirty years ago, the Early Treatment Diabetic Retinopathy Study (ETDRS) demonstrated that focal/grid laser photocoagulation...
8.
Martinez-Castillo V, Garcia-Arumi J, Boixadera A
Ophthalmology . 2016 Apr; 123(7):1563-9. PMID: 27126928
Purpose: To report the surgical results of primary pseudophakic rhegmatogenous retinal detachment (RRD) with only inferior retinal breaks (IRBs) repaired by pars plana vitrectomy (PPV) alone and complete drainage of...
9.
Martinez-Castillo V, Boixadera A, Distefano L, Zapata M, Garcia-Arumi J
Retina . 2012 Mar; 32(7):1350-5. PMID: 22414957
Purpose: To compare outcomes of eyes that did or did not develop an epiretinal membrane (ERM) after repair of primary pseudophakic or aphakic rhegmatogenous retinal detachment by pars plana vitrectomy...
10.
Garcia-Arumi J, Boixadera A, Martinez-Castillo V, Zapata M, Fonollosa A, Corcostegui B
Retina . 2011 May; 31(9):1777-82. PMID: 21606891
Purpose: To review the surgical management and functional outcome of macular holes (MHs) developing after rhegmatogenous retinal detachment repair. Methods: Retrospective, interventional, noncomparative case series. Twenty patients with MH developing...